ArticleMolecular cancer2025

KF1601, a dual inhibitor of BCR::ABL1 and FLT3, overcomes drug resistance in FLT3

Hyun-Jin Kwon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.